Riskpilot← Back to searchSign inGet full accessIMED AS
ASActiveOrg 913022319Christian Michelsens Gate Nord 2, 3715 SkienOther human health activities n.e.c. · NACE 8699Est. 20147 employees
Revenue 2024
NOK 10,2M
+7% vs 2023
EBITDA margin
41.0%
+5% vs 2023
Equity ratio
67.9%
Financial strength
Net profit 2024
NOK 4,9M
+54% vs 2023
| Revenue | NOK 10,2M | +7% |
| EBITDA | NOK 4,2M | +5% |
| Net profit | NOK 4,9M | +54% |
| Total assets | NOK 10,9M | +42% |
| Equity | NOK 7,4M | +55% |
| Employees | 7 | — |
Legal name
IMED AS
Org number
913022319
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
4. januar 2014
Share capital
NOK 40 207
Employees
7 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Øyelegevirksomhet samt annen virksomhet som faller naturlig inn under dette. Videre kjøp/salg og drift av fast eiendom, kjøp/salg av aksjer og andre verdipapirer og hva som står i forbindelse med dette.
Address
Christian Michelsens Gate Nord 2, 3715 Skien
Phone
+4735520505
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4 799 | 5 079 | 5 101 | 5 519 | 6 123 | 7 445 | 9 422 | 9 989 | 9 632 | 9 564 | 10 216 |
| Staff expenses | −1 836 | −1 766 | −1 861 | −1 981 | −2 037 | −2 115 | −2 020 | −2 274 | −2 539 | −2 710 | −2 160 |
| EBITDA | 2 279 | 2 505 | 2 533 | 2 553 | 2 899 | 2 878 | 3 578 | 4 301 | 4 340 | 3 979 | 4 189 |
| Depreciation & amort. | −209 | −325 | −347 | −390 | −533 | −369 | −461 | −489 | −471 | −437 | −245 |
| EBIT | 2 070 | 2 179 | 2 185 | 2 163 | 2 366 | 2 510 | 3 117 | 3 812 | 3 869 | 3 542 | 3 944 |
| Net financials | −4 | 1 | 23 | 58 | −27 | 104 | 107 | 142 | −154 | 413 | 1 836 |
| Profit before tax | 2 065 | 2 180 | 2 209 | 2 221 | 2 339 | 2 614 | 3 224 | 3 954 | 3 715 | 3 955 | 5 781 |
| Tax | 559 | 588 | 546 | 520 | 548 | 554 | 687 | 840 | 853 | 787 | 890 |
| Net profit | 1 507 | 1 592 | 1 663 | 1 701 | 1 790 | 2 060 | 2 538 | 3 114 | 2 862 | 3 168 | 4 891 |
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 2 403 | 2 557 | 2 609 | 2 689 | 2 906 | 3 596 | 4 828 | 4 595 | 5 961 | 7 673 | 10 905 |
| Equity | 49 | 51 | 714 | 1 019 | 122 | 1 091 | 1 129 | 1 742 | 3 105 | 4 773 | 7 403 |
| Long-term debt | 5 | 16 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 2 350 | 2 491 | 1 895 | 1 669 | 2 784 | 2 505 | 3 699 | 2 853 | 2 857 | 2 900 | 3 501 |
| Total debt | 2 354 | 2 507 | 1 895 | 1 669 | 2 784 | 2 505 | 3 699 | 2 853 | 2 857 | 2 900 | 3 501 |
EBITDA margin
41.0%
This company
15.8%
Market median
+159% vs market
20142024
Equity ratio
67.9%
This company
38.2%
Market median
+78% vs market
20142024
Return on equity
66.1%
This company
18.4%
Market median
+259% vs market
20142024
Net profit margin
47.9%
This company
8.1%
Market median
+491% vs market
20142024
Asset turnover
0.94×
This company
1.12×
Market median
+16% vs market
20142024
Debt / equity
0.47×
This company
0.62×
Market median
+24% vs market
20142024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2013-12-01 – 2014-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
ÅR Chief Executive Officer | Chief Executive Officer | 2014 | — | — |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
IMED AS 
TELEMARK AUGEKLINIKK ASBoard members of IMED AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Åsne Romtveit | Chief Executive Officer | 0 companies |